135 related articles for article (PubMed ID: 16858127)
1. Ischemia/reperfusion injury in the monolayers of human intestinal epithelial cell line caco-2 and its recovery by antioxidants.
Nagira M; Tomita M; Mizuno S; Kumata M; Ayabe T; Hayashi M
Drug Metab Pharmacokinet; 2006 Jun; 21(3):230-7. PubMed ID: 16858127
[TBL] [Abstract][Full Text] [Related]
2. Clarification of the mechanism of structural change induced by reoxygenation following the induction of lipid peroxidation in Caco-2 cell monolayers.
Tomita M; Nagira M; Haga M; Hayashi M
Drug Metab Pharmacokinet; 2002; 17(1):83-91. PubMed ID: 15618656
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic analysis for drug permeation through intestinal membrane.
Hayashi M; Tomita M
Drug Metab Pharmacokinet; 2007 Apr; 22(2):67-77. PubMed ID: 17495413
[TBL] [Abstract][Full Text] [Related]
4. Effects of antioxidants on drug absorption in in vivo intestinal ischemia/reperfusion.
Takizawa Y; Kitazato T; Kishimoto H; Tomita M; Hayashi M
Eur J Drug Metab Pharmacokinet; 2011 Jan; 35(3-4):89-95. PubMed ID: 21302034
[TBL] [Abstract][Full Text] [Related]
5. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers.
Rege BD; Kao JP; Polli JE
Eur J Pharm Sci; 2002 Sep; 16(4-5):237-46. PubMed ID: 12208453
[TBL] [Abstract][Full Text] [Related]
6. Regional difference in P-glycoprotein function in rat intestine.
Iida A; Tomita M; Hayashi M
Drug Metab Pharmacokinet; 2005 Apr; 20(2):100-6. PubMed ID: 15855720
[TBL] [Abstract][Full Text] [Related]
7. Effects of capsaicin on cellular damage and monolayer permeability in human intestinal Caco-2 cells.
Tsukura Y; Mori M; Hirotani Y; Ikeda K; Amano F; Kato R; Ijiri Y; Tanaka K
Biol Pharm Bull; 2007 Oct; 30(10):1982-6. PubMed ID: 17917278
[TBL] [Abstract][Full Text] [Related]
8. Intestinal P-glycoprotein expression is multimodally regulated by intestinal ischemia-reperfusion.
Terada Y; Ogura J; Tsujimoto T; Kuwayama K; Koizumi T; Sasaki S; Maruyama H; Kobayashi M; Yamaguchi H; Iseki K
J Pharm Pharm Sci; 2014; 17(2):266-76. PubMed ID: 24934555
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of hypoxia and LPS-induced intestinal epithelial barrier dysfunction by emodin through the suppression of the NF-κB and HIF-1α signaling pathways.
Lei Q; Qiang F; Chao D; Di W; Guoqian Z; Bo Y; Lina Y
Int J Mol Med; 2014 Dec; 34(6):1629-39. PubMed ID: 25318952
[TBL] [Abstract][Full Text] [Related]
10. Rhodamine 123 requires carrier-mediated influx for its activity as a P-glycoprotein substrate in Caco-2 cells.
Troutman MD; Thakker DR
Pharm Res; 2003 Aug; 20(8):1192-9. PubMed ID: 12948017
[TBL] [Abstract][Full Text] [Related]
11. Effects of intestinal ischemia/reperfusion on P-glycoprotein mediated biliary and renal excretion of rhodamine123 in rat.
Tomita M; Kishimoto H; Takizawa Y; Hayashi M
Drug Metab Pharmacokinet; 2009; 24(5):428-37. PubMed ID: 19881254
[TBL] [Abstract][Full Text] [Related]
12. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
[TBL] [Abstract][Full Text] [Related]
13. Cytokine-induced intestinal epithelial hyperpermeability: role of nitric oxide.
Chavez AM; Menconi MJ; Hodin RA; Fink MP
Crit Care Med; 1999 Oct; 27(10):2246-51. PubMed ID: 10548215
[TBL] [Abstract][Full Text] [Related]
14. Ferulate protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in tert-butyl hydroperoxide-induced Caco-2 cells.
Kim HJ; Lee EK; Park MH; Ha YM; Jung KJ; Kim MS; Kim MK; Yu BP; Chung HY
Phytother Res; 2013 Mar; 27(3):362-7. PubMed ID: 22610911
[TBL] [Abstract][Full Text] [Related]
15. Assessment of ileal epithelial P-glycoprotein dysfunction induced by ischemia/reperfusion using in vivo animal model.
Tomita M; Takizawa Y; Kishimoto H; Hayashi M
Drug Metab Pharmacokinet; 2008; 23(5):356-63. PubMed ID: 18974613
[TBL] [Abstract][Full Text] [Related]
16. Induction of drug efflux protein expression by venlafaxine but not desvenlafaxine.
Bachmeier CJ; Beaulieu-Abdelahad D; Ganey NJ; Mullan MJ; Levin GM
Biopharm Drug Dispos; 2011 May; 32(4):233-44. PubMed ID: 21446053
[TBL] [Abstract][Full Text] [Related]
17. Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines.
van der Sandt IC; Blom-Roosemalen MC; de Boer AG; Breimer DD
Eur J Pharm Sci; 2000 Sep; 11(3):207-14. PubMed ID: 11042226
[TBL] [Abstract][Full Text] [Related]
18. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.
Döppenschmitt S; Spahn-Langguth H; Regårdh CG; Langguth P
J Pharm Sci; 1999 Oct; 88(10):1067-72. PubMed ID: 10514357
[TBL] [Abstract][Full Text] [Related]
19. Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers.
Troutman MD; Thakker DR
Pharm Res; 2003 Aug; 20(8):1200-9. PubMed ID: 12948018
[TBL] [Abstract][Full Text] [Related]
20. Early downregulation of P-glycoprotein facilitates bacterial attachment to intestinal epithelial cells and thereby triggers barrier dysfunction in a rodent model of total parenteral nutrition.
Zhang T; Liu Y; Yan JK; Cai W
FASEB J; 2020 Mar; 34(3):4670-4683. PubMed ID: 32027421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
